(Q47914486)

6 February 2018

title

Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790698

5 March 2023

neoplasm antigens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790698

5 March 2023

active immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790698

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

author name string

M. Moore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790698

5 March 2023

D. E. Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4790698

5 March 2023

language of work or name

English

0 references

publication date

1 March 1973

1 reference

6 February 2018

15 March 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4790698

full work available at URL

5 March 2023

number of pages

11

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910110213

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910110213

5 March 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

International Journal of Cancer

5 March 2023

published in

1 reference

6 February 2018

volume

11

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

358-368

1 reference

6 February 2018

The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910110213

Studies on the antigenicity of radiation-induced murine osteosarcomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910110213

Demonstration of cell-surface antigens on chemically induced tumors

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Prolongation of Homograft Survival in Mice with Single Doses of Cyclophosphamide

5 March 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

5

25

859

Bradner

1965

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence

5 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine Fibrosarcomas

5 March 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

9

29

2177

Fefer

1969

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Immunotherapy of primary moloney sarcoma-virus-induced tumors

5 March 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

11

27

456

Ferrer

1967

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Antitumor Effects of Kethoxal-Bis(Thiosemicarbazone) and 6-Mercaptopurine in Neonatally Thymeetomized Mice

5 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Relationship Between Tumor Incompatibility and Therapeutic Response

5 March 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

14

29

515

Glynn

1969

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

15

32

298

Griswold

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs

5 March 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

17

30

2841

Kalpaktsoglou

1970

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

18

20

452

Klein

1960

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

19

20

1561

Klein

1960

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Effect of cyclophosphamide on syngeneic transplantation of para-adenovirus-7-transformed tumor cells in hamsters

5 March 2023

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

The Recovery of Immune Responsiveness after Treatment with Cyclophosphamide

5 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

24

22

218

Mihich

1962

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Proportional increase in the theta carrying lymphocytes in peripheral lymphoid tissue following treatment with cyclophosphamide.

5 March 2023

27

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

30

21

1412

Sugiura

1961

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Chemotherapy of Solid Tumors

5 March 2023

31

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice

5 March 2023

33

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

Treatment of Burkitt's tumor with cyclophosphamide

5 March 2023

34

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110213

5 March 2023

Identifiers

1 reference

6 February 2018

1 reference

6 February 2018